Experiment 68505
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | VOGT,HJ: BRANDL,P: KOCKOTT,G: SCHMITZ,JR: WIEGAND,MH: SCHADRACK,J: GIEREND,M:. (1997). DOUBLE-BLIND, PLACEBO-CONTROLLED SAFETY AND EFFICACY TRIAL WITH YOHIMBINE HYDROCHLORIDE IN THE TREATMENT OF NONORGANIC ERECTILE DYSFUNCTION.. 9(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | THIS DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF YOHIMBINE HYDROCHLORIDE INCLUDED 86 PATIENTS WITH ERECTILE DYSFUNCTION AND WITHOUT CLEARLY DETECTABLE ORGANIC OR PSYCHLOGIC CAUSES. OBJECTIVE CRITERIA OF OUTCOME WERE BASED ON IMPROVEMENT IN PENILE RIGIDITY DETERMINED BY USE OF POLYSOMNOGRAPHY IN THE SLEEP LABORATORY. OVERALL YOHIMBINE WAS FOUND SIGNIFICANTLY MORE EFFECTIVE THAN PLACEBO IN TERMS OF RESPONSE RATE: 71 VS 45%. YOHIMBINE WAS WELL-TOLERATED: ONLY 7% OF PATIENTS RATED TOLERABILITY FAIR TO POOR, AND MOST ADVERSE EXPERIENCES WERE MILD. THERE WERE NO SERIOUS ADVERSE EVENTS. |
| Dose amount | 30.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | MALE |